NCT05989074View on ClinicalTrials.gov

All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve

NAUnknownINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Aortic Stenosis, Severe
Interventions
DEVICE

ALLEGRA TAVI System TF

Patients receive ALLEGRA TAVI System TF. Patient will receive medication according to routine practice of the hospital

DEVICE

Ballon-expandable valve system

Patients receive any kind of CE-marked balloon expandable valve system, used at the hospital. Patient will receive medication according to routine practice of the hospital.

Sponsors

Collaborators (1)

Biosensors International
All Listed Sponsors
collaborator

Biosensors International

OTHER

collaborator

European Cardiovascular Research Center

NETWORK

lead

Ceric Sàrl

INDUSTRY

NCT05989074 - All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve | Biotech Hunter | Biotech Hunter